Table 2.
Individual Adverse Reactions With Oral Ingestion of N-Acetylcysteine Solution
| Adverse reaction | Dose
|
|||
|---|---|---|---|---|
| 0 mg/kg | 35 mg/kg | 70 mg/kg | 140 mg/kg | |
| Gastrointestinal | ||||
| upset stomach | — | H1, I1 | F1, H1, I2 | A1, C1, D2, E1, I1, J1 |
| nausea | — | — | — | C1, H1, J1 |
| stomach or intestinal gas | F1, H1 | E1, F1 | F1, I3 | A1, C2, D2, F2, I2, J1 |
| Nongastrointestinal | ||||
| sleepiness | A1, D1, H1 | D1 | B1, C1, D1 | F1, I1 |
| metallic taste | J2 | A1 | A1, D1, I1 | A1, H1, I1, J1 |
| light-headedness | H1 | — | D1 | J1 |
| redness of eye, face, or hands | F1 | — | — | — |
| cough | — | — | D1 | — |
Note. Uppercase letters (A–J) refer to individual subjects from Arm 2. Superscripts show ranked intensity of adverse reactions reported by each subject. Ranked intensities are (1) mild, (2) moderate, and (3) severe. Subjects who indicated “none” (0) for an adverse reaction are omitted for clarity. None of the subjects experienced welts or wheezing. See Table 1 for further details.